PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8156174-2	1993	Chemiluminescence was stimulated with zymosan opsonized by fresh plasma (IgG- and C3b-dependent chemiluminescence) or by complement-depleted plasma (IgG-dependent chemiluminescence).	Zymosan	38-45	endogenous retrovirus group K member 3	Homo sapiens	82-85	
10897414-1	2000	The present study demonstrates that stimulation of human neutrophils with opsonized zymosan (OZ), which binds to Fc gamma receptors (Fc gamma Rs) and C3b receptors, activates both ERK and p38 MAP-kinase.	Zymosan	84-91	endogenous retrovirus group K member 3	Homo sapiens	150-153	
6462133-0	1981	The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.	Zymosan	107-114	endogenous retrovirus group K member 3	Homo sapiens	100-103	
6197357-7	1984	Additions of H also inhibited HRA generation in fresh serum when induced with plain or C3b-coated zymosan (Z) particles.	Zymosan	98-105	endogenous retrovirus group K member 3	Homo sapiens	87-90	
2839364-2	1988	On the other hand, the response to the C3b/Fc receptor stimulus, opsonized zymosan, was marginally decreased whilst that to the Fc receptor stimulus, aggregated IgG, was virtually unaffected.	Zymosan	75-82	endogenous retrovirus group K member 3	Homo sapiens	39-42	
2944730-1	1986	The red cell C3b receptor activity of 52 patients with esophageal cancer, 19 patients with cancer of gastric cardia and 31 age-matched normal persons was studied by the ability of forming ZC3b-rosette (rosette formation with zymosan particles treated by guinea pig complement) and IC-Z rosette (rosette formation with zymosan particles).	Zymosan	225-232	endogenous retrovirus group K member 3	Homo sapiens	13-16	
6462133-1	1981	The covalent binding of complement fragment C3b to zymosan by the action of the alternative-pathway C3 convertase and the reversible binding of several complement proteins (component C5, factor B, beta 1H and properdin) to C3b on zymosan have been investigated.	Zymosan	51-58	endogenous retrovirus group K member 3	Homo sapiens	44-47	
6462133-1	1981	The covalent binding of complement fragment C3b to zymosan by the action of the alternative-pathway C3 convertase and the reversible binding of several complement proteins (component C5, factor B, beta 1H and properdin) to C3b on zymosan have been investigated.	Zymosan	51-58	endogenous retrovirus group K member 3	Homo sapiens	223-226	
6462133-1	1981	The covalent binding of complement fragment C3b to zymosan by the action of the alternative-pathway C3 convertase and the reversible binding of several complement proteins (component C5, factor B, beta 1H and properdin) to C3b on zymosan have been investigated.	Zymosan	230-237	endogenous retrovirus group K member 3	Homo sapiens	44-47	
6462133-1	1981	The covalent binding of complement fragment C3b to zymosan by the action of the alternative-pathway C3 convertase and the reversible binding of several complement proteins (component C5, factor B, beta 1H and properdin) to C3b on zymosan have been investigated.	Zymosan	230-237	endogenous retrovirus group K member 3	Homo sapiens	223-226	
6462133-2	1981	When C3b is deposited on zymosan after activation by a surface-bound C3 convertase, the C3b molecules are deposited in foci around the C3 convertase site, with an average of 30 C3b molecules per site.	Zymosan	25-32	endogenous retrovirus group K member 3	Homo sapiens	5-8	
6462133-2	1981	When C3b is deposited on zymosan after activation by a surface-bound C3 convertase, the C3b molecules are deposited in foci around the C3 convertase site, with an average of 30 C3b molecules per site.	Zymosan	25-32	endogenous retrovirus group K member 3	Homo sapiens	88-91	
6462133-2	1981	When C3b is deposited on zymosan after activation by a surface-bound C3 convertase, the C3b molecules are deposited in foci around the C3 convertase site, with an average of 30 C3b molecules per site.	Zymosan	25-32	endogenous retrovirus group K member 3	Homo sapiens	88-91	
6462133-3	1981	The association constants of C5, factor B, beta 1H, and properdin for C3b bound to zymosan have been determined.	Zymosan	83-90	endogenous retrovirus group K member 3	Homo sapiens	70-73	
7263071-7	1981	Blocking of alternative pathway activation with either zymosan incubation or heat treatment decreased the number of both syncytial and nonsyncytial cells stained for C3b.	Zymosan	55-62	endogenous retrovirus group K member 3	Homo sapiens	166-169